National Ovarian Cancer Awareness Month, 2022, 54299-54300 [2022-19282]

Agencies

• Executive Office of the President

[Federal Register Volume 87, Number 171 (Tuesday, September 6, 2022)]
[Presidential Documents]
[Pages 54299-54300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19282]




                        Presidential Documents 



Federal Register / Vol. 87, No. 171 / Tuesday, September 6, 2022 / 
Presidential Documents

[[Page 54299]]


                Proclamation 10433 of August 31, 2022

                
National Ovarian Cancer Awareness Month, 2022

                By the President of the United States of America

                A Proclamation

                This year, nearly 20,000 women in the United States 
                will be diagnosed with ovarian cancer. Hard to detect 
                and frequently discovered in advanced stages, this 
                disease is often deadly for so many. Structural 
                barriers inhibit access to quality and affordable 
                health care, and documented disparities in treatment 
                can lead to higher mortality rates for Black women and 
                elderly women in particular. During Ovarian Cancer 
                Awareness Month, our Nation honors those who are 
                struggling with this dreaded disease, remembers the 
                loved ones we have lost, and recommits to ending 
                ovarian cancer--and all cancer--as we know it.

                This issue is personal to me and the First Lady, as it 
                is for so many families. Earlier this year, we 
                reignited the Cancer Moonshot Initiative which I 
                oversaw in 2016. The Cancer Moonshot Initiative has a 
                goal of cutting the cancer death rate in half--at 
                least--over the next 25 years. My Administration also 
                created, and the Congress has funded, the Advanced 
                Research Projects Agency for Health (ARPA-H) at the 
                National Institutes of Health to revolutionize the way 
                we detect and treat diseases like cancer, Alzheimer's, 
                and diabetes. With improved screening and early 
                detection technologies, diagnostics, treatments, and 
                supportive care, we are on the cusp of real 
                breakthroughs. The incidence of ovarian cancer has 
                decreased over the last decades as survival rates have 
                increased.

                Of course, there is more work to do. I promised to 
                protect and build on the Affordable Care Act (ACA), and 
                that is exactly what my Administration will do--
                including by guaranteeing protections for women with 
                preexisting conditions and preventing insurance 
                companies from dropping patients with ovarian cancer. 
                The ACA covers visits to a primary care physician and 
                gynecologist without copayments or deductibles, which 
                can lead to earlier detection of ovarian cancer. We 
                must also increase diversity in clinical trials to 
                ensure that new treatments will work for everyone and 
                to better understand why ovarian cancer impacts some 
                Americans more than others. My Administration will 
                continue supporting the National Institutes of Health, 
                the Food and Drug Administration, and other agencies as 
                they broaden outreach to racial and ethnic minority 
                populations and other underrepresented groups and 
                assess whether cancer treatments will be effective for 
                the diverse range of patients who need them.

                Expanding access to care is especially critical as we 
                emerge from the COVID-19 pandemic. In the early days of 
                the pandemic, Americans missed almost 10 million cancer 
                screenings. Medical experts in my Administration and 
                around the country encourage women to reschedule these 
                appointments as soon as possible. Additionally, the 
                Centers for Disease Control and Prevention's (CDC) 
                ``Inside Knowledge about Gynecologic Cancer'' website 
                is a useful resource for information on ovarian cancer. 
                For people who think they may be at risk for this 
                disease, experts have compiled helpful information 
                about ovarian cancer at cancer.gov/types/ovarianandcdc.gov/cancer. Being informed is a first 
                step toward prevention.

                As we observe National Ovarian Cancer month, we will 
                never forget those we have lost. We honor our health 
                care experts who work tirelessly to

[[Page 54300]]

                save lives. And we offer strength to women and families 
                across this country fighting ovarian cancer today and 
                in the future.

                NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of 
                the United States of America, by virtue of the 
                authority vested in me by the Constitution and the laws 
                of the United States, do hereby proclaim September 2022 
                as National Ovarian Cancer Awareness Month. I call upon 
                the people of the United States to speak with their 
                doctors and health care providers to learn more about 
                ovarian cancer. I encourage citizens, government 
                agencies, private businesses, nonprofit organizations, 
                the media, and other interested groups to increase 
                awareness of what Americans can do to detect and treat 
                ovarian cancer.

                IN WITNESS WHEREOF, I have hereunto set my hand this 
                thirty-first day of August, in the year of our Lord two 
                thousand twenty-two, and of the Independence of the 
                United States of America the two hundred and forty-
                seventh.
                
                
                    (Presidential Sig.)

[FR Doc. 2022-19282
Filed 9-2-22; 8:45 am]
Billing code 3395-F2-P